Sign In
Buy TNDM
$18.03
-0.570 (-3.06%)
At Close: Jun 03, 2026
Tandem Diabetes Gains 45.7% in a Year: What's Driving the Stock?
08:26am, Wednesday, 22'nd Jan 2025
TNDM's shares rise as its expanding product portfolio gains market traction. However, the unfavorable macroeconomic scenario is concerning.
Reasons to Retain TNDM Stock in Your Portfolio for Now
07:11am, Tuesday, 21'st Jan 2025
A robust diabetes market and several strategic developments raise investors' optimism for Tandem Diabetes.
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
04:05pm, Wednesday, 15'th Jan 2025
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2024 results after
Tandem Diabetes Forges New R&D Agreement With UVA: Stock to Gain?
09:20am, Thursday, 09'th Jan 2025
TNDM enters a multi-year research collaboration with the UVA Center for Diabetes Technology for the development of AID systems.
SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced it has signed a multi-year collabor
TNDM Stock to Gain From t:slim X2 With Dexcom G7 Launch in Canada
09:45am, Friday, 13'th Dec 2024
Tandem Diabetes' t:slim X2 insulin pump is now compatible with Dexcom G7 CGM in Canada.
Reasons to Retain TNDM Stock in Your Portfolio for Now
09:51am, Friday, 06'th Dec 2024
Innovations and a robust international market expansion raise investors' optimism for Tandem Diabetes.
Tandem Diabetes Care Announces Upcoming Conference Presentations
04:05pm, Thursday, 21'st Nov 2024
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the
TNDM Q3 Earnings Beat, '24 Sales View Up, Stock Falls in Aftermarket
09:31am, Friday, 08'th Nov 2024
Tandem Diabetes' top and bottom lines outpace estimates in the third quarter, backed by the demand for both t:slim X2 and the newly launched Tandem Mobi.
Tandem Diabetes Care, Inc. (TNDM) Q3 2024 Earnings Conference Call Transcript
09:21pm, Wednesday, 06'th Nov 2024
Tandem Diabetes Care, Inc. (TNDM) Q3 2024 Earnings Conference Call Transcript
Tandem Diabetes Care (TNDM) Reports Q3 Earnings: What Key Metrics Have to Say
07:36pm, Wednesday, 06'th Nov 2024
While the top- and bottom-line numbers for Tandem Diabetes Care (TNDM) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key
Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates
06:26pm, Wednesday, 06'th Nov 2024
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $0.38 per share a year ago.
Tandem Diabetes Care Announces Upcoming Conference Participation
04:05pm, Wednesday, 30'th Oct 2024
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will host meetings and present a comp
Down -21.69% in 4 Weeks, Here's Why Tandem Diabetes Care (TNDM) Looks Ripe for a Turnaround
10:35am, Friday, 18'th Oct 2024
Tandem Diabetes Care (TNDM) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts
Tandem Diabetes Insulin Pump Demand to Surge Despite Popular Demand Of Weight Loss Drugs, Bullish Analyst Says
02:11pm, Wednesday, 02'nd Oct 2024
RBC Capital Markets initiated coverage on Tandem Diabetes Care, Inc. TNDM, a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery sys
